Recently Approved Cell-Based Gene Therapies Demonstrate Innovation in Sickle Cell Disease Treatment

Download our white paper Recently Approved Cell-Based Gene Therapies Demonstrate Innovation in Sickle Cell Disease Treatment to learn more about the evolving therapies for curing Sickle Cell Disease (SCD). This white paper offers a comprehensive primer on the burden of SCD, the patient journey, and current and emerging treatment options.

Evolving therapies for curing SCD:

  • Allogeneic Stem Cell Transplant
  • Autologous Stem Cell Transplant
  • Interfering MicroRNA
  • Gene Therapy

Sickle Cell Disease poses significant health and economic burdens, understanding the latest advancements in treatment is crucial for healthcare providers. UBC’s Judy Lytle, PhD, MBEE, PMP, Bruce Smith, PharmD, and Don Gabriel, MD, PhD discuss integrated evidence generation strategies for gene therapy and other new and emerging therapeutics in this white paper.

Get started by completing the form to access our white paper Recently Approved Cell-Based Gene Therapies Demonstrate Innovation in Sickle Cell Disease Treatment.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.